Author Topic: (Abst.) Efficacy of rituximab in refractory RRMS  (Read 114 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9817
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Efficacy of rituximab in refractory RRMS
« on: May 04, 2018, 02:21:14 pm »

This French study concerns a group of RRMS patients who had continued to progress in spite of taking natalizumab (Tysabri), mitoxantrone (Novantrone) or fingolimod (Gilenya)  and who were given rituximab (Rituxan).

From PubMed, May 4, 2018:


https://www.ncbi.nlm.nih.gov/pubmed/29722639
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
131 Views
Last post October 29, 2016, 06:34:51 am
by agate
0 Replies
128 Views
Last post December 19, 2017, 02:43:17 pm
by agate
0 Replies
31 Views
Last post December 02, 2020, 03:35:02 pm
by agate
0 Replies
28 Views
Last post August 20, 2021, 09:26:22 pm
by agate
4 Replies
2363 Views
Last post November 27, 2023, 04:18:36 pm
by agate